Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
A

ABEO

Nasdaq

ABEONA THERAPEUTICS INC.

Latest disclosureSeptember 29, 2026
Insider score Why 0?
0/ 100
Qualifying buys · 30d
$0

0 purchases · 25 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 28

Limited filing history
All28Buying0Selling25Other3
Filters

Last 30 daysNo qualifying insider buying. Sales: $208.43K by 4 insiders.

3 of 28 trades · March 31, 2026 – September 29, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.
Other activity disclosed

Madhav Vasanthavada

Chief Commercial Officer

Common Stock

Value context
$1.26K
Reported price
$5.67 / share
Traded June 16, 2026Filed June 17, 2026SEC filing
Gift disclosed

Mark Alvino

Director

Common Stock

Value context
Not a purchase
Reported price
Gift · no purchase price
Understand this price

The filing reports a zero transaction price for this gift. It does not establish the market value of the gift.

Traded May 26, 2026Filed May 26, 2026SEC filing
Award disclosed

Keith A. Goldan

Director

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 1, 2026Filed April 7, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
Chief Commercial OfficerCommon StockOther transaction222$5.67 / share$1.26KJun 16Filed Jun 17 · 1d laterSEC filing
DirectorCommon StockGift500Gift · no purchase priceNot a purchaseMay 26Filed May 26 · 0d laterSEC filing
DirectorCommon StockGrant or award32,751Award · no purchase priceNon-cash awardApr 1Filed Apr 7 · 6d laterSEC filing

Congress transactions 0

All Congress filings
No disclosed congressional trades for ABEO in the imported filings.

This reflects the filings imported so far, not a complete trading history.

Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0000318306
Latest public acceptance
Sep 30, 2026, 01:48 AM UTC
Score calculated
Oct 7, 2026, 12:04 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.